Want to see SE:XBRANE full AI Analyst Report?
Xbrane Biopharma AB (XBRANE) Income Statement
Xbrane Biopharma AB Income Statement
Last quarter (Q3 2026), Xbrane Biopharma AB's total revenue was $54.77M, an increase of 441.31% from the same quarter last year. In Q3, Xbrane Biopharma AB's net income was $-11.72M. See Xbrane Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 152.35M | $ 198.70M | $ 238.73M | $ 57.62M | $ 11.53M | |
| $ 74.94M | $ 180.47M | $ 35.39M | $ 41.04M | $ -684.00K | |
| $ 151.71M | $ 398.40M | $ 357.55M | $ 210.27M | $ 191.93M | |
| Depreciation and Amortization | $ 14.60M | $ 35.95M | $ 21.43M | $ 16.58M | $ 12.22M |
| $ -16.50M | $ -181.97M | $ -282.03M | $ -149.34M | $ -168.37M | |
| $ -72.14M | $ -217.92M | $ -310.43M | $ -166.22M | $ -180.40M | |
| $ 28.21M | $ -35.51M | $ -11.60M | $ -2.30M | $ -2.64M | |
| $ -43.93M | $ -253.43M | $ -322.03M | $ -168.51M | $ -183.23M | |
| $ 127.24M | $ -266.22M | $ -388.17M | $ -172.23M | $ -191.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.08 | $ -27.50 | $ -158.75 | $ -96.25 | $ -112.50 |
| Diluted EPS | $ 0.08 | $ -27.50 | $ -158.75 | $ -96.25 | $ -112.50 |
| Weighted Average Shares Outstanding | 1.52B | 9.84M | 2.03M | 1.80M | 1.66M |
| Weighted Average Shares Outstanding (Diluted) | 1.52B | 9.84M | 2.03M | 1.80M | 1.66M |
Currency in SEK
